ASTEX PHARMACEUTICALS INC's ticker is ASTX and the CUSIP is 04624B103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $62,000 | – | 15,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Centaur Capital | 370,000 | $1,521,000 | 1.70% |
| Perceptive Advisors | 1,649,423 | $6,779,000 | 0.68% |
| Perimeter Capital Partners, LLC | 770,661 | $3,167,000 | 0.61% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 1,173,119 | $4,821,000 | 0.59% |
| Peak Ten Capital LLC | 100,000 | $411,000 | 0.50% |
| J. Goldman & Co LP | 775,000 | $3,185,000 | 0.32% |
| Orbimed Advisors | 3,256,100 | $13,383,000 | 0.28% |
| Spark Investment Management LLC | 247,900 | $1,016,000 | 0.27% |
| OXFORD ASSET MANAGEMENT LLP | 1,078,743 | $4,434,000 | 0.12% |
| EAM Investors, LLC | 133,254 | $548,000 | 0.12% |